Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes.
Glycodeoxycholate (GDC) induces apoptosis in hepatocytes by a mechanism associated with DNA cleavage by endonucleases. In many models of apoptosis, proteolysis is required prior to DNA cleavage. Our aims were to determine if enhanced proteolysis is a mechanism causing GDC-mediated apoptosis. In cultured rat hepatocytes exposed to 50 microM GDC for 4 h, nonlysosomal proteolysis increased by 65% compared with controls. The serine protease inhibitor N alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK; 100 microM) reduced cell death from apoptosis by 75% after 4 h of treatment with GDC. TLCK also inhibited DNA fragmentation. There was a twofold increase in nuclear serinelike protease activity during GDC-induced apoptosis accompanied by a 2.5-fold reduction in nonnuclear serine protease activity, suggesting translocation of the protease from the cytosol to the nucleus. Zn2+, an inhibitor of apoptosis, also inhibited nonlysosomal proteolysis and nuclear serinelike protease activity. These novel data suggest that nonlysosomal serinelike protease activity contributes to hepatocyte apoptosis. These data may be important in understanding apoptosis in other cell types and in providing insight into the mechanisms of liver injury during cholestasis.
Kwo
P
P
Center for Basic Research in Digestive Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA.
Patel
T
T
Bronk
S F
SF
Gores
G J
GJ
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001647:Bile Acids and Salts / Q000494:pharmacology*; D002154:Calpain / Q000494:pharmacology; D020170:Caspase 1; D002467:Cell Nucleus / Q000201:enzymology*; D003546:Cysteine Endopeptidases / Q000494:pharmacology; D006002:Glycodeoxycholic Acid / Q000494:pharmacology; D008099:Liver / Q000166:cytology* / Q000187:drug effects* / Q000201:enzymology; D008247:Lysosomes / Q000378:metabolism; D008297:Male; D010447:Peptide Hydrolases / Q000378:metabolism; D011480:Protease Inhibitors / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012697:Serine Endopeptidases / Q000378:metabolism*; D015032:Zinc / Q000494:pharmacology
D001647:Bile Acids and Salts; D011480:Protease Inhibitors; D006002:Glycodeoxycholic Acid; D010447:Peptide Hydrolases; D012697:Serine Endopeptidases; D002154:Calpain; D003546:Cysteine Endopeptidases; D020170:Caspase 1; D015032:Zinc